|
|
| Line 7: |
Line 7: |
| |blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content) | | |blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content) |
| |fdaLIADAdult=<h4>Condition 1</h5> | | |fdaLIADAdult=<h4>Condition 1</h5> |
|
| |
| * Dosing Information
| |
|
| |
| :: (Dosage)
| |
| }}
| |
| __NOTOC__
| |
| {{Carvedilol}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
|
| |
| '''''For patient information, click <u>[[Carvedilol (patient information)|here]]'''''</u>.
| |
|
| |
| {{SB}} COREG®, COREG CR®
| |
|
| |
| ==Overview==
| |
|
| |
| ==Category==
| |
|
| |
| ==FDA Package Insert==
| |
|
| |
| '''| [[Carvedilol indications and usage|Indications and Usage]]'''
| |
| '''| [[Carvedilol dosage and administration|Dosage and Administration]]'''
| |
| '''| [[Carvedilol dosage forms and strengths|Dosage Forms and Strengths]]'''
| |
| '''| [[Carvedilol contraindications|Contraindications]]'''
| |
| '''| [[Carvedilol warnings|Warnings and Precautions]]'''
| |
| '''| [[Carvedilol adverse reactions|Adverse Reactions]]'''
| |
| '''| [[Carvedilol drug interactions|Drug Interactions]]'''
| |
| '''| [[Carvedilol use in specific populations|Use in Specific Populations]]'''
| |
| '''| [[Carvedilol overdosage|Overdosage]]'''
| |
| '''| [[Carvedilol description|Description]]'''
| |
| '''| [[Carvedilol clinical pharmacology|Clinical Pharmacology]]'''
| |
| '''| [[Carvedilol nonclinical toxicology|Nonclinical Toxicology]]'''
| |
| '''| [[Carvedilol clinical studies|Clinical Studies]]'''
| |
| '''| [[Carvedilol how supplied storage and handling|How Supplied/Storage and Handling]]'''
| |
| '''| [[Carvedilol patient counseling information|Patient Counseling Information]]'''
| |
| '''| [[Carvedilol labels and packages|Labels and Packages]]'''
| |
|
| |
| ==Mechanism of Action==
| |
|
| |
| ==References==
| |
|
| |
| {{Reflist|2}}
| |
|
| |
| [[Category:Drugs]]
| |
Revision as of 11:17, 3 April 2014
{{DrugProjectFormSinglePage
|authorTag=Abdurahman Khalil, M.D. [1]
|genericName=Carvedilol
|drugClass=Alpha-adrenergic blocker, Beta-adrenergic blocker
|indication=Heart failure of ischemic or cardiomyopathic origin, hypertension
|adverseReactions=Fatigue, hypotension, dizziness, hyperglycemia
|blackBoxWarningBody=Condition Name: (Content)
|fdaLIADAdult=<h4>Condition 1</h5>